Clinical Trials Insight: 700053496

Trial Profile

Clinical Trials Insight: 700053496

Phase of Trial: Phase I

Latest Information Update: 07 Jan 2011

At a glance

  • Drugs IPI 940 (Primary)
  • Indications Inflammatory pain; Neuropathic pain
  • Focus Adverse reactions
  • Sponsors Infinity Pharmaceuticals
  • Most Recent Events

    • 07 Jan 2011 Infinity Pharmaceuticals expect commencement of the phase I development to be initiated, according to an Infinity Pharmaceuticals media release.
    • 12 Feb 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top